Patents-Review.com
🔗 Permalink
Assignee profile:

BioVersys AG

City:

Basel

Country:

Switzerland

Published Applications:

23

Last publication date:

2025-11-27

Patent Grants:

22

Last grant date:

2025-09-02

Top Inventors for applications by BioVersys AG

These are the the leading inventors for applications assigned to BioVersys AG:

Recent patent applications by BioVersys AG

BioVersys AG based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-11-27
US20250360115A1
Human necessities

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

 #2 | 2024-06-20 ✅ Patent 12,403,133 granted on 2025-09-02
US20240197697A1
Human necessities

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

 #3 | 2024-02-08 ✅ Patent 12,257,241 granted on 2025-03-25
US20240041845A1
Human necessities

Rifabutin treatment methods, uses, and compositions

 #4 | 2024-01-04 ✅ Patent 12,370,184 granted on 2025-07-29
US20240000759A1
Human necessities

ANTIBIOTIC COMBINATION THERAPIES

 #5 | 2023-08-10 ✅ Patent 12,297,201 granted on 2025-05-13
US20230250101A1
Chemistry; metallurgy

Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials

 #6 | 2023-05-04 ✅ Patent 11,833,139 granted on 2023-12-05
US20230132691A1
Human necessities

Rifabutin treatment methods, uses, and compositions

 #7 | 2023-03-02 ✅ Patent 11,903,934 granted on 2024-02-20
US20230066182A1
Human necessities

Rifabutin treatment methods, uses, and compositions

 #8 | 2022-04-14 ✅ Patent 11,999,739 granted on 2024-06-04
US20220112197A1
Chemistry; metallurgy

Antimicrobials methods of making and using the same

 #9 | 2022-01-27 ✅ Patent 12,509,462 granted on 2025-12-30
US20220024928A1
Chemistry; metallurgy

3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES

 #10 | 2021-08-19 ✅ Patent 12,152,031 granted on 2024-11-26
US20210253577A1
Chemistry; metallurgy

Biodefense agents

 #11 | 2021-06-10 ✅ Patent 12,234,238 granted on 2025-02-25
US20210171533A1
Chemistry; metallurgy

Antimicrobial compounds and methods of making and using the same

 #12 | 2021-03-18 ✅ Patent 11,207,305 granted on 2021-12-28
US20210077472A1
Human necessities

Antibiotic combination therapies

 #13 | 2021-03-18 ✅ Patent 11,351,158 granted on 2022-06-07
US20210077471A1
Human necessities

Rifabutin treatment methods, uses, and compositions

 #14 | 2021-03-18 ✅ Patent 11,344,537 granted on 2022-05-31
US20210077470A1
Human necessities

Rifabutin treatment methods, uses, and compositions

 #15 | 2021-02-04 ✅ Patent 11,254,689 granted on 2022-02-22
US20210032268A1
Chemistry; metallurgy

Compounds

 #16 | 2020-08-13 ✅ Patent 11,969,423 granted on 2024-04-30
US20200253967A1
Human necessities

Compounds

 #17 | 2020-06-04 ✅ Patent 11,253,499 granted on 2022-02-22
US20200170997A1
Human necessities

Compounds

 #18 | 2020-01-16 ✅ Patent 11,098,047 granted on 2021-08-24
US20200017504A1
Chemistry; metallurgy

Antimicrobials and methods of making and using same

 #19 | 2019-09-19 ✅ Patent 10,815,238 granted on 2020-10-27
US20190284190A1
Chemistry; metallurgy

Antimicrobial compounds and methods of making and using the same

 #20 | 2019-07-11 ✅ Patent 10,934,295 granted on 2021-03-02
US20190211018A1
Chemistry; metallurgy

Antimicrobials and methods of making and using same

 #21 | 2019-06-27 ✅ Patent 10,815,237 granted on 2020-10-27
US20190194205A1
Chemistry; metallurgy

Antimicrobials and methods of making and using same

 #22 | 2018-03-08 ✅ Patent 10,947,237 granted on 2021-03-16
US20180065966A1
Chemistry; metallurgy

Antimicrobial compounds and methods of making and using the same

 #23 | 2012-04-26 ✅ Patent 8,912,329 granted on 2014-12-16
US20120101080A1
Human necessities

Composition for treatment of tuberculosis

Also check out BIOVERSYS AG's (Basel, Switzerland) applicant profile with 33 patent applications submitted.

AssigneeID:

181116 ⎘